Vitamin E levels during chemotherapy for ovarian carcinoma.
Ananth
N
N
Shetty
Beena V
BV
Vasudevan
D M
DM
D000328:Adult; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000188:drug therapy*; D002945:Cisplatin / Q000009:adverse effects; D005047:Etoposide / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000188:drug therapy*; D014810:Vitamin E / Q000097:blood*
D000972:Antineoplastic Agents, Phytogenic; D014810:Vitamin E; D005047:Etoposide; D002945:Cisplatin